Greenwich LifeSciences (GLSI) Provides Update on Phase III Trial
Go back to Greenwich LifeSciences (GLSI) Provides Update on Phase III Trial| (NASDAQ: GLSI) | Delayed: 19.01 +0.44 (2.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.57 | 52 Week High | $ | |||
| Open | $18.93 | 52 Week Low | $ | |||
| Day High | $19.35 | P/E | N/A | |||
| Day Low | $18.28 | EPS | $ | |||
| Volume | 93,514 | |||||

